Abstract:BACKGROUND: The molecular mechanism of blood vessel endothelium formation is the primary premise for cellular and gene replacement therapy. OBJECTIVE: To construct an eukaryotic expression plasmid for cellular repressor of E1A-stimulated genes (CREG) driven by an endothelial cell specific promoter TIE2 and reported by enhanced green fluorescence protein (EGFP), and then to observe its expression in mouse artery endothelial cells in vitro. METHODS: TIE2 promoter DNA sequence was synthesized according to GenBank, and was attached with Ase I and Nhe I restriction enzyme recognition sites at both ends, respectively. The TIE2 promoter sequence was released from pUC57-TIE2 plasmid by Ase I and Nhe I digestion enzymes, and then was inserted into pEGFP-N1 plasmid to form pTIE2-EGFP-N1 recombinant plasmid. CREG gene fragment was released from pcDNA3.1 myc-His/hCREG plasmid by BamH I and EcoR I digestion enzymes, and then was subcloned into pTIE2-EGFP-N1 plasmid in order to construct pTIE2-CREG-EGFP-N1 plasmid. The recombinant pTIE2-CREG-EGFP-N1 plasmid was then transfected into mouse artery endothelial cells by liposome. The EGFP expression was observed by fluorescence microscopy and the CREG expression was detected by western blot analysis. RESULTS AND CONCLUSION: Identification of pTIE2-CREG-EGFP-N1 by enzyme digestion and sequencing analysis showed that lengths of the target genes which were inserted into the recombinant plasmid were correct, and that the recombinant plasmid was transfected into mouse artery endothelial cells successfully. The strong expression of EGFP was observed by fluorescence microscopy, and the expression of CREG protein was detected by western blot analyis. The results showed that the pTIE2-CREG-EGFP-N1 eukaryotic expression plasmid was successfully constructed and the recombinant vector provides a practical tool in investigating the function and regulation of CREG in the development of cardiovascular diseases and also in producing transgenic mice with endothelial cell specific over-expression of CREG.

Establishment of stable over-expressing human SIRT1 HEK293 cell line

Construction of hsa-miR-152lentiviral vector and screening of cell strain for stable expression

Construction and identification of eukaryotic plasmid expression vectors encoding the short hairpin RNA targeting human SIRT1

Cloning and Stable Expression in NIH3T3 Cells of Human Stnfr1

Construction and verification of eukaryotic expression plasmid carring human HO-1 gene

Establishment of an ATDC5 cell model with lentivirus-mediated SIRT1 gene knockdown*

Construction and Identification of Eukaryotic Expressed Plasmid Vector Plenti6/v5- DEST-Cx43 in Human

Establishment of A549 cell line with stable expression of HIF1α mediated by lentiviral vector

[Construction of SOD1 Eukaryotic Expression Vector and Its Expression].

The Establishment and Identification of the Stable Transfectant of HeLa Cell Expressing Human New Gene( PCIA1)

Construction of eukaryotic vector of human sTNFR1

Establishment of a Hepatocyte Line from Human with SV40LT Antigen

Construction and identification of eukaryotic expression plasmid of recombinant human hypoxia-inducible factor-1α

Construction of Eukaryotic Expression Plasmid of Human GSTP1 and Establishment of NCI-H520 Cell Line Stably Transfected with the Constructed Plasmid

Construction of a stable expression HEK293T engineered cell line adapted to high-density suspension culture

Establishment of a HEK293 cell line by CRISPR/Cas9-mediated luciferase knock-in to study transcriptional regulation of the human SREBP1 gene

Establishment of Heparanase Stable Expression Cell Lines

[Construction and identification of a HEK293 cell line with stable TrxR1 overexpression].

Construction of PTIE2-CREG-EGFP-N1 eukaryotic expression plasmid and its expression in mouse artery endothelial cells

Establishment of a Stable AT1R-expressed and Aβ Secretion HEK293 Cell Line

Construction of Sirt1~(-/-) Cell Line in HCT116